openPR Logo
Press release

Metastatic Cancer Treatment Market to Reach USD 137.31 Billion by 2030, Growing at a CAGR of 7.3%

01-09-2025 05:57 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: MAXIMIZE MARKET RESEARCH PVT. LTD.

Metastatic Cancer Treatment Market

Metastatic Cancer Treatment Market

๐†๐ฅ๐จ๐›๐š๐ฅ ๐Œ๐ž๐ญ๐š๐ฌ๐ญ๐š๐ญ๐ข๐œ ๐‚๐š๐ง๐œ๐ž๐ซ ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ญ๐จ ๐‘๐ž๐š๐œ๐ก ๐”๐’๐ƒ ๐Ÿ–๐Ÿ•.๐Ÿ‘ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ‘๐ŸŽ, ๐†๐ซ๐จ๐ฐ๐ข๐ง๐  ๐š๐ญ ๐š ๐‚๐€๐†๐‘ ๐จ๐Ÿ ๐Ÿ—.๐Ÿ%

The global Metastatic Cancer Treatment Market was valued at USD 41.5 billion in 2023 and is projected to grow at a robust CAGR of 9.1% from 2024 to 2030, reaching USD 87.3 billion by 2030. Increasing incidences of cancer, rising awareness about early detection and treatment options, and the development of innovative therapies are the key drivers of this market's growth.

๐Š๐ž๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ:

๐‘๐ข๐ฌ๐ข๐ง๐  ๐‚๐š๐ง๐œ๐ž๐ซ ๐๐ซ๐ž๐ฏ๐š๐ฅ๐ž๐ง๐œ๐ž : Metastatic cancer, a condition where cancer cells spread from the primary site to other parts of the body, is on the rise, necessitating advanced treatment options.

๐€๐๐ฏ๐š๐ง๐œ๐ž๐ฆ๐ž๐ง๐ญ๐ฌ ๐ข๐ง ๐ˆ๐ฆ๐ฆ๐ฎ๐ง๐จ-๐Ž๐ง๐œ๐จ๐ฅ๐จ๐ ๐ฒ : The development of immunotherapies and targeted therapies has transformed the treatment of metastatic cancers, increasing their market adoption.

๐†๐ซ๐จ๐ฐ๐ข๐ง๐  ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐„๐ฑ๐ฉ๐ž๐ง๐๐ข๐ญ๐ฎ๐ซ๐ž: With the rising number of cancer patients, healthcare investments in innovative treatment options have increased globally.

๐‹๐จ๐จ๐ค๐ข๐ง๐  ๐Ÿ๐จ๐ซ ๐ฆ๐จ๐ซ๐ž ๐ข๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง? ๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐š ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐จ๐ซ ๐ข๐ง๐ช๐ฎ๐ข๐ซ๐ž ๐ง๐จ๐ฐ : https://www.maximizemarketresearch.com/request-sample/22159/

๐Œ๐ž๐ญ๐š๐ฌ๐ญ๐š๐ญ๐ข๐œ ๐‚๐š๐ง๐œ๐ž๐ซ ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐ข๐ง ๐ญ๐ก๐ž ๐”๐’: ๐’๐ฎ๐ซ๐ ๐ž ๐ข๐ง ๐ˆ๐ฆ๐ฆ๐ฎ๐ง๐จ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ฒ ๐€๐๐ฏ๐š๐ง๐œ๐ž๐ฆ๐ž๐ง๐ญ๐ฌ

The US remains the largest market for metastatic cancer treatments, driven by cutting-edge cancer research and a well-established healthcare infrastructure. The demand for advanced immunotherapies such as Keytruda (from Merck), Opdivo (from Bristol-Myers Squibb), and targeted therapies has led to rapid growth in this sector. The National Cancer Institute's funding for metastatic cancer research is expected to further propel the market. Additionally, the recent merger between Gilead Sciences and Immunomedics is expected to enhance the US market with innovative metastatic cancer treatments, particularly for breast cancer.

๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐Ÿ๐จ๐ซ ๐Œ๐ž๐ญ๐š๐ฌ๐ญ๐š๐ญ๐ข๐œ ๐‚๐š๐ง๐œ๐ž๐ซ ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐ข๐ง ๐•๐ข๐ž๐ญ๐ง๐š๐ฆ: ๐„๐ฑ๐ฉ๐š๐ง๐๐ข๐ง๐  ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐’๐ž๐œ๐ญ๐จ๐ซ

In Vietnam, the metastatic cancer treatment market is seeing substantial growth due to increased healthcare investments and the rising cancer burden. As cancer diagnoses rise, there is an increasing demand for advanced cancer treatments like chemotherapy, immunotherapy, and targeted therapy. Vietlife Pharma and Vinmec Healthcare System are leading in providing cutting-edge cancer treatment options. The Vietnamese government's emphasis on improving healthcare infrastructure and expanding access to cancer treatments provides strong growth opportunities for global pharmaceutical companies to expand their reach.

๐“๐ซ๐ž๐ง๐๐ฌ ๐ข๐ง ๐“๐ก๐š๐ข๐ฅ๐š๐ง๐: ๐‘๐ข๐ฌ๐ข๐ง๐  ๐ƒ๐ž๐ฆ๐š๐ง๐ ๐Ÿ๐จ๐ซ ๐“๐š๐ซ๐ ๐ž๐ญ๐ž๐ ๐‚๐š๐ง๐œ๐ž๐ซ ๐“๐ก๐ž๐ซ๐š๐ฉ๐ข๐ž๐ฌ

In Thailand, the metastatic cancer treatment market is expanding rapidly, particularly with the increased use of targeted therapies and immunotherapies. Thai Pharmaceutical Companies such as Biomed and Siam Pharma are advancing their oncology offerings to cater to the growing need for metastatic cancer treatments. Government initiatives aimed at improving cancer care and oncology research are expected to create new opportunities for innovative treatments in the country. The growing prevalence of cancer in Thailand, combined with the government's push for healthcare reform, supports the adoption of advanced treatments like immunotherapies and biologics.

๐‚๐จ๐ง๐ฌ๐จ๐ฅ๐ข๐๐š๐ญ๐ข๐จ๐ง ๐จ๐Ÿ ๐Œ๐ž๐ญ๐š๐ฌ๐ญ๐š๐ญ๐ข๐œ ๐‚๐š๐ง๐œ๐ž๐ซ ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ข๐ง ๐‰๐š๐ฉ๐š๐ง

Japan is a key player in the metastatic cancer treatment market, thanks to its advanced healthcare system and the increasing use of innovative therapies. Companies like Takeda Pharmaceutical and Astellas Pharma are at the forefront of developing new metastatic cancer treatment options. Takeda's acquisition of TiGenix and its focus on immuno-oncology are expected to significantly enhance its portfolio for treating metastatic cancers, particularly gastrointestinal and hematologic cancers. The Japanese market is also experiencing an increase in clinical trials focused on developing targeted therapies for metastatic breast and lung cancer.

๐Œ๐ž๐ญ๐š๐ฌ๐ญ๐š๐ญ๐ข๐œ ๐‚๐š๐ง๐œ๐ž๐ซ ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐ข๐ง ๐’๐จ๐ฎ๐ญ๐ก ๐Š๐จ๐ซ๐ž๐š: ๐„๐ฆ๐ฉ๐ก๐š๐ฌ๐ข๐ฌ ๐จ๐ง ๐๐ซ๐ž๐œ๐ข๐ฌ๐ข๐จ๐ง ๐Œ๐ž๐๐ข๐œ๐ข๐ง๐ž

South Korea is rapidly emerging as a key market for metastatic cancer treatments, driven by advancements in precision medicine and cancer genomics. South Korean biotech companies like Samsung Biologics and Celltrion Healthcare are developing novel biologics and immunotherapies, expanding treatment options for metastatic cancers. The country's push toward personalized medicine, particularly through genetic profiling, is fueling the demand for targeted therapies for metastatic cancer. LG Life Sciences has made significant advancements in precision oncology, contributing to South Korea's growing influence in the global metastatic cancer treatment market.

๐Œ๐ž๐ญ๐š๐ฌ๐ญ๐š๐ญ๐ข๐œ ๐‚๐š๐ง๐œ๐ž๐ซ ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐ข๐ง ๐’๐ข๐ง๐ ๐š๐ฉ๐จ๐ซ๐ž: ๐‡๐ฎ๐› ๐Ÿ๐จ๐ซ ๐‚๐š๐ง๐œ๐ž๐ซ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐š๐ง๐ ๐ˆ๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง

Singapore's well-established reputation as a hub for medical research and innovation is driving the demand for advanced metastatic cancer treatments. With its state-of-the-art healthcare facilities and emphasis on clinical trials, the country is experiencing rapid growth in the market for targeted and immunotherapy treatments. Companies like Novartis Singapore, AstraZeneca, and Merck are leading the charge in providing advanced cancer therapies in the region. The government's funding for cancer research, combined with its efforts to position Singapore as a global leader in medical research, is expected to drive significant growth in the metastatic cancer treatment market.

๐Œ๐ž๐ญ๐š๐ฌ๐ญ๐š๐ญ๐ข๐œ ๐‚๐š๐ง๐œ๐ž๐ซ ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐”๐ฉ๐๐š๐ญ๐ข๐จ๐ง ๐ข๐ง ๐„๐ฎ๐ซ๐จ๐ฉ๐ž: ๐…๐จ๐œ๐ฎ๐ฌ ๐จ๐ง ๐๐ž๐ซ๐ฌ๐จ๐ง๐š๐ฅ๐ข๐ณ๐ž๐ ๐Ž๐ง๐œ๐จ๐ฅ๐จ๐ ๐ฒ

In Europe, the metastatic cancer treatment market is undergoing significant transformations, with growing focus on personalized oncology. The use of genetic testing to identify suitable treatments for metastatic cancers is gaining momentum. Companies such as Roche, Sanofi, and Bayer are developing innovative treatments, including immunotherapies and gene therapies, tailored to individual patients. The European Medicines Agency (EMA) has approved several new cancer treatments, encouraging the use of personalized medicine across the continent. With the aging population and rising cancer incidences, Europe presents immense opportunities for the growth of the metastatic cancer treatment market.

Key Recent Developments:

๐’๐ญ๐ซ๐š๐ญ๐ž๐ ๐ข๐œ ๐๐š๐ซ๐ญ๐ง๐ž๐ซ๐ฌ๐ก๐ข๐ฉ๐ฌ ๐ข๐ง ๐ญ๐ก๐ž ๐”๐’ : In 2023, Bristol-Myers Squibb and Sangamo Therapeutics announced a partnership to develop gene therapies for metastatic cancers, enhancing the treatment landscape.

๐„๐ฑ๐ฉ๐š๐ง๐ฌ๐ข๐จ๐ง ๐ข๐ง ๐‰๐š๐ฉ๐š๐ง : Takeda Pharmaceutical completed the acquisition of TiGenix to expand its oncology portfolio, focusing on developing novel treatments for metastatic cancer.

๐‚๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ ๐“๐ซ๐ข๐š๐ฅ๐ฌ ๐ข๐ง ๐’๐จ๐ฎ๐ญ๐ก ๐Š๐จ๐ซ๐ž๐š : Celltrion Healthcare initiated Phase III clinical trials for a new biologic therapy targeting metastatic colorectal cancer, reinforcing the country's role in advancing cancer treatment.

๐…๐จ๐ซ ๐ฆ๐จ๐ซ๐ž ๐๐ž๐ญ๐š๐ข๐ฅ๐ฌ ๐š๐ง๐ ๐ข๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐ซ๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐š ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐จ๐ซ ๐ข๐ง๐ช๐ฎ๐ข๐ซ๐ž ๐ญ๐จ๐๐š๐ฒ :https://www.maximizemarketresearch.com/request-sample/22159/

๐ƒ๐ข๐ฌ๐œ๐จ๐ฏ๐ž๐ซ ๐ค๐ž๐ฒ ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ๐ฌ ๐๐ซ๐ข๐ฏ๐ข๐ง๐  ๐ญ๐ก๐ž ๐ ๐ซ๐จ๐ฐ๐ญ๐ก ๐จ๐Ÿ ๐ญ๐ก๐ž ๐Œ๐ž๐ญ๐š๐ฌ๐ญ๐š๐ญ๐ข๐œ ๐‚๐š๐ง๐œ๐ž๐ซ ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐Œ๐š๐ซ๐ค๐ž๐ญ :

๐›๐ฒ ๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง

Breast Cancer
Lung Cancer
Melanoma
Prostate Cancer
Colorectal Cancer
Others

The market is divided into several segments based on the application, including colorectal cancer, prostate cancer, lung cancer, breast cancer, and melanoma. By 2030, it is anticipated that the breast cancer category will hold the biggest market shares, at xxx%. This is because breast cancer is becoming more common worldwide, there is a greater need for improved imaging and detection technologies to identify metastatic breast cancer, and there is a greater focus on research and development to find new treatments for metastatic breast cancer.

๐›๐ฒ ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐“๐ฒ๐ฉ๐ž

ChemotherapyHormone Therapy

Immunotherapy
Others

The market is divided into four segments based on the type of treatment: chemotherapy, hormone therapy, immunotherapy, and others. The chemotherapy treatment segment is anticipated to have the largest market shares of xx% by 2030 because chemotherapy is becoming a more popular therapeutic option for metastatic cancer. Among other things, chemotherapy is used alone or in combination with other treatments like surgery and radiotherapy to delay the progression of cancer, stop the growth of cancer cells, and effectively kill metastatic cancer cells.

๐›๐ฒ ๐„๐ง๐ ๐”๐ฌ๐ž

Hospital
Clinics
Research Institutes
Others

The market is divided into hospitals, clinics, research institutes, and others based on the end use. The hospital segment is anticipated to expand at a compound annual growth rate (CAGR) of xxx% from 2024 to 2030. This is because of things like the growing number of people receiving treatment for metastatic cancer and the increasing incidence of metastatic cancer disorders. Additionally, hospital treatment for metastatic cancer is more expensive, which raises market income.

๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐๐ž๐ญ๐š๐ข๐ฅ๐ž๐ ๐๐š๐ญ๐š ๐š๐ง๐ ๐ข๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐›๐ฒ ๐ฏ๐ข๐ž๐ฐ๐ข๐ง๐  ๐ญ๐ก๐ž ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž : @https://www.maximizemarketresearch.com/market-report/global-metastatic-cancer-treatment-market/22159/ ๏ปฟ

๐‹๐ž๐š๐ซ๐ง ๐š๐›๐จ๐ฎ๐ญ ๐ญ๐ก๐ž ๐ญ๐จ๐ฉ ๐ฉ๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ ๐๐ซ๐ข๐ฏ๐ข๐ง๐  ๐ข๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง ๐ข๐ง ๐ญ๐ก๐ž ๐Œ๐ž๐ญ๐š๐ฌ๐ญ๐š๐ญ๐ข๐œ ๐‚๐š๐ง๐œ๐ž๐ซ ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐Œ๐š๐ซ๐ค๐ž๐ญ :

1. AbbVie, Inc.
2. Amgen, Inc.
3. AstraZeneca PLC
4. Bayer AG
5. Boehringer Ingelheim International GmbH
6. BRISTOL-MYERS SQUIBB COMPANY
7. CELGENE CORPORATION
8. Eli-Lilly and Company
9. F. Hoffmann-La Roche AG
10.JOHNSON & JOHNSON
11.Merck & Co., Inc.
12.Novartis AG
13.Pfizer, Inc.
14.SANOFI
15.Takeda Pharmaceutical Company Limited
16.Bluebird bio, Inc.
17.Clovis Oncology, Inc.
18.IDERA PHARMACEUTICALS, INC.

๐†๐ž๐ญ ๐š๐ง๐ฌ๐ฐ๐ž๐ซ๐ฌ ๐ญ๐จ ๐œ๐ซ๐ข๐ญ๐ข๐œ๐š๐ฅ ๐ช๐ฎ๐ž๐ฌ๐ญ๐ข๐จ๐ง๐ฌ ๐ฌ๐ก๐š๐ฉ๐ข๐ง๐  ๐ญ๐ก๐ž ๐Œ๐ž๐ญ๐š๐ฌ๐ญ๐š๐ญ๐ข๐œ ๐‚๐š๐ง๐œ๐ž๐ซ ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐Œ๐š๐ซ๐ค๐ž๐ญ :

What is Metastatic Cancer Treatment ?
What is the growth rate of the Metastatic Cancer Treatment Market?
Which are the factors expected to drive the Metastatic Cancer Treatment market growth?
What is the CAGR at which the Metastatic Cancer Treatment market will grow during the forecast period?
What are the different segments of the Metastatic Cancer Treatment Market?
Which is the fastest growing region in the Metastatic Cancer Treatment market?
What growth strategies are the players considering to increase their presence in Metastatic Cancer Treatment ?
What are the upcoming opportunities and trends for the Metastatic Cancer Treatment Market?
What are the recent industry trends that can be implemented to generate additional revenue streams for the Metastatic Cancer Treatment Market?
Who are the leading companies and what are their portfolios in Metastatic Cancer Treatment Market?
What segments are covered in the Metastatic Cancer Treatment Market?
Who are the key players in the Metastatic Cancer Treatment market?

๐†๐š๐ข๐ง ๐š๐œ๐œ๐ž๐ฌ๐ฌ ๐ญ๐จ ๐ฏ๐š๐ฅ๐ฎ๐š๐›๐ฅ๐ž ๐ข๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐ข๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐ญ๐ก๐ซ๐จ๐ฎ๐ ๐ก ๐ญ๐ก๐ž ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž ๐ฅ๐ข๐ง๐ค @https://www.maximizemarketresearch.com/request-sample/22159/

๐†๐ž๐ญ ๐š ๐œ๐ฅ๐จ๐ฌ๐ž๐ซ ๐ฅ๐จ๐จ๐ค ๐š๐ญ ๐ญ๐ก๐ž ๐ ๐š๐ฆ๐ž-๐œ๐ก๐š๐ง๐ ๐ข๐ง๐  ๐ฉ๐ซ๐จ๐๐ฎ๐œ๐ญ๐ฌ ๐๐ซ๐ข๐ฏ๐ข๐ง๐  ๐ฌ๐ฎ๐œ๐œ๐ž๐ฌ๐ฌ.

Past Size and Competitive Landscape
โ€ข Past Pricing and price curve by region
โ€ข Size, Share, Size Forecast by different segment
โ€ข Dynamics Growth Drivers, Restraints, Opportunities, and Key Trends by Region
โ€ข Segmentation A detailed analysis by segment with their sub-segments and Region
โ€ข Competitive Landscape Profiles of selected key players by region from a strategic perspective

๐‚๐ก๐ž๐œ๐ค ๐จ๐ฎ๐ญ ๐จ๐ฎ๐ซ ๐ญ๐ซ๐ž๐ง๐๐ข๐ง๐  ๐ฌ๐ญ๐ฎ๐๐ข๐ž๐ฌ ๐ญ๐จ ๐ฎ๐ง๐๐ž๐ซ๐ฌ๐ญ๐š๐ง๐ ๐ข๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐ฌ๐ก๐ข๐Ÿ๐ญ๐ฌ :

โ™ฆ Cider Market https://www.maximizemarketresearch.com/market-report/global-cider-market/27300/

โ™ฆ India Gem & Jewellery Market https://www.maximizemarketresearch.com/market-report/india-gem-jewellery-market/122565/

โ™ฆ India Bottled Water Market https://www.maximizemarketresearch.com/market-report/india-bottled-water-market/20197/

โ™ฆ India Smart Home Installation Service market https://www.maximizemarketresearch.com/market-report/india-smart-home-installation-service-market/41757/

โ™ฆ Global Upstream Petrotechnical Training Services Market https://www.maximizemarketresearch.com/market-report/global-upstream-petrotechnical-training-services-market/41423/

โ™ฆ Global Ambient Light Sensor Market https://www.maximizemarketresearch.com/market-report/global-ambient-light-sensor-market/62760/

โ™ฆ Global Body Scrub Products Market https://www.maximizemarketresearch.com/market-report/global-body-scrub-products-market/108141/

โ™ฆ Global Safety Eyewear Market https://www.maximizemarketresearch.com/market-report/global-safety-eyewear-market/111306/

โ™ฆ Digital Out of Home (DOOH) Market https://www.maximizemarketresearch.com/market-report/digital-out-of-home-dooh-market/146851/

โ™ฆ Temporary Power Market https://www.maximizemarketresearch.com/market-report/global-temporary-power-market/105417/

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

๐‘๐ž๐š๐œ๐ก ๐Ž๐ฎ๐ญ ๐ญ๐จ ๐Œ๐š๐ฑ๐ข๐ฆ๐ข๐ณ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐Ÿ๐จ๐ซ ๐ˆ๐ง-๐ƒ๐ž๐ฉ๐ญ๐ก ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐š๐ง๐ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ :

MAXIMIZE MARKET RESEARCH PVT. LTD.
3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
sales@maximizemarketresearch.com
www.maximizemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Metastatic Cancer Treatment Market to Reach USD 137.31 Billion by 2030, Growing at a CAGR of 7.3% here

News-ID: 3808419 • Views: โ€ฆ

More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.

Global Magnesium Alloys Market Poised to Grow from US$ 2.21 Billion in 2024 to US$ 5.58 Billion by 2032 at a CAGR of 12.25% - Magnesium Alloys Market Forecast
09-03-2025 | Advertising, Media Consulting, โ€ฆ
MAXIMIZE MARKET RESEARCH PVT. LTD.
Global Magnesium Alloys Market Poised to Grow from US$ 2.21 Billion in 2024 to U โ€ฆ
According to a new report by Maximizer Market Research, the Global Magnesium Alloys Market was valued at USD 2.21 billion in 2024 and is projected to reach USD 5.58 billion by 2032, growing at a CAGR of 12.25%. This growth is underpinned by rising demand from automotive & transportation, electronics, aerospace, defense, and medical industries seeking lightweight, high-performance materials. For full access to the data, request a sample report now :https://www.maximizemarketresearch.com/request-sample/32753/ โ™ฆโ€ฆ
Global Bamboo Furniture Market to Grow from USD 13.75 Billion to USD 23.02 Billion by 2032 at a CAGR of 6.65% - Bamboo Furniture Forecast
09-03-2025 | Advertising, Media Consulting, โ€ฆ
MAXIMIZE MARKET RESEARCH PVT. LTD.
Global Bamboo Furniture Market to Grow from USD 13.75 Billion to USD 23.02 Billi โ€ฆ
According to a new report by Maximize Market Research, the global bamboo furniture market was valued at USD 13.75 billion in 2024 and is projected to reach USD 23.02 billion by 2032, growing at a compound annual growth rate (CAGR) of approximately 6.65%. For full access to the data, request a sample report now :https://www.maximizemarketresearch.com/request-sample/111043/ โ™ฆ Key Highlights โ™ฆ Market size & CAGR: USD 13.75 billion (2024) to USD 23.02 billion (2032) atโ€ฆ
Open-Source Intelligence Market Projected to Reach USD 23,887 Million by 2030
09-03-2025 | Advertising, Media Consulting, โ€ฆ
MAXIMIZE MARKET RESEARCH PVT. LTD.
Open-Source Intelligence Market Projected to Reach USD 23,887 Million by 2030
Open-Source Intelligence Market size was valued at USD 6425.89 Million in 2023 and the total Open-Source Intelligence revenue is expected to grow at a CAGR of 20.63 % from 2024 to 2030, reaching nearly USD 23887.37 Million by 2030. Open-Source Intelligence Market Overview: The Open-Source Intelligence (OSINT) market is a rapidly expanding sector within the broader security and intelligence landscape. It involves the systematic collection, analysis, and interpretation of publicly available informationโ€ฆ
Pension Administration Software Market to Surge from USD 4.89 Bn (2023) to USD 10.89 Bn by 2030 at 12.1% CAGR - Pension Administration Software Forecast to Drive Digital Transformation
09-03-2025 | Advertising, Media Consulting, โ€ฆ
MAXIMIZE MARKET RESEARCH PVT. LTD.
Pension Administration Software Market to Surge from USD 4.89 Bn (2023) to USD 1 โ€ฆ
According to a new report by Maximize Market Research, the global pension administration software market was valued at USD 4.89 billion in 2023 and is projected to grow to USD 10.89 billion by 2030, registering a robust CAGR of 12.1% over the forecast period (2024-2030). This growth is expected worldwide, fueled by increasing digitalization, automation, and demand for predictive analytics in retirement plan management. For full access to the data, requestโ€ฆ

All 5 Releases


More Releases for Cancer

05-12-2021 | Health & Medicine
Allied Market Research
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by โ€ฆ
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emergingโ€ฆ
11-11-2020 | Health & Medicine
QualiKet Research
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio โ€ฆ
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boostโ€ฆ
04-16-2019 | Science & Education
The Insight Partners
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne โ€ฆ
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of theโ€ฆ
11-12-2018 | Health & Medicine
Crystal Market Research - Healthcare
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve โ€ฆ
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:โ€ฆ
07-24-2018 | Health & Medicine
Pharmaceutical Report
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance โ€ฆ
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launchโ€ฆ
06-23-2017 | Health & Medicine
Tumor Ablation
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung โ€ฆ
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. Forโ€ฆ